ACS Publications. Most Trusted. Most Cited. Most Read
Possible Inhibition of Atherosclerosis by a Flavonoid Isolated from Young Green Barley Leaves
My Activity

Possible Inhibition of Atherosclerosis by a Flavonoid Isolated from Young Green Barley Leaves

  • Takashi Miyake
    Takashi Miyake
    Department of Environmental Toxicology, University of California, Davis, CA 95616
  • Yashihide Hagiwara
    Yashihide Hagiwara
    Department of Environmental Toxicology, University of California, Davis, CA 95616
  • Hideaki Hagiwara
    Hideaki Hagiwara
    Hagiwara Institute of Health, 1173 Maruyama, Asazuma-cho, Kasai 679-01, Japan
  • , and 
  • Takayuki Shibamoto
    Takayuki Shibamoto
    Department of Environmental Toxicology, University of California, Davis, CA 95616
DOI: 10.1021/bk-1998-0702.ch017
    Publication Date (Print):August 21, 1998
    Copyright © 1998 American Chemical Society.
    Functional Foods for Disease Prevention II
    Chapter 17pp 178-186
    ACS Symposium SeriesVol. 702
    ISBN13: 9780841235731eISBN: 9780841216778

    Chapter Views

    51

    Citations

    LEARN ABOUT THESE METRICS

    Chapter Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    Other access options

    Abstract

    Young green barley leaves are known to possess potent pharmacological properties, including antioxidative, anti-inflammatory, antimutagenic, and antiallergic activities. In particular, an flavonoid, 2"-O-glycosylisovitexin (2"-O-GIV), isolated from an ethanol extract of young green barley leaves, possesses a strong inhibitory effect toward lipid peroxidation. 2"-O-GIV inhibited acetaldehyde formation from LDL by 76% at a level of 1 µmol/50 µg, whereas ferulic acid inhibited by 66% at the same level. In a case of a blood plasma system, 2"-O-GIV and probucol inhibited acetaldehyde formation by 89% and 94%, respectively, at a level of 3 µmol. 2"-O-GIV and vitamin C inhibited MDA formation by 54% and 32%, respectively, at a level of 0.1 µmol. A synergetic effect between 2"-O-GIV and vitamin C was observed.

    Read this chapter

    To access this chapter, please review the available access options below.

    Get instant access

    Purchase Access

    Read this chapter for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this chapter through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.